United States-based global pharmaceutical company MSD said on Monday that China's National Medical Products Administration has approved the use of multiple new indications of Gardasil®9, its ...

AIIMS Delhi has developed a blood test using ddPCR tech to detect HPV DNA for early cervical cancer detection, relapse ...

We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going ...

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.

Union Health Ministry plans HPV vaccination for girls aged 9-14 to prevent cervical cancer, with capacity building for frontline workers.

MSD's Gardasil 9, which is India's first gender-neutral HPV vaccine, is also available. The 9-valent HPV vaccine targets sub-types 6, 11, 16, 18, 31, 33, 45, 52 and 58 among Indian girls and women ...

In the current report, Merck announced their fourth-quarter and full-year 2024 financial results, in which it stated that "GARDASIL/GARDASIL 9 [s]ales [d]eclined 3% to $8.6 Billion." In addition, the ...

Merck has a strong vaccine business, thanks to the human papillomavirus (HPV) products Gardasil and Gardasil 9. It's also a leader in the animal health business. However, its shares underperformed ...

MSD's Gardasil 9, which is India's first gender-neutral HPV vaccine, is also available. The 9-valent HPV vaccine targets sub-types 6, 11, 16, 18, 31, 33, 45, 52 and 58 among Indian girls and women ...